French biotech company opens US headquarters in Pittsburgh to begin clinical trials on diabetes drug

A French biotech company developing a new type 2 diabetes drug is opening its American headquarters in Pittsburgh. KDKA money editor Jon Delano spoke with the company’s chairman on Monday afternoon to find out what this all means.